Lovo-cel (bb1111) Gene Therapy for Sickle Cell Disease: Updated Clinical Results and Investigations into Two Cases of Anemia from Group C of the Phase 1/2 HGB-206 Study

Walters, M. C., Thompson, A. A., Kwiatkowski, J. L., Parikh, S., Mapara, M. Y., Rifkin-Zenenberg, S., Aygun, B., Kasow, K. A., Miller, A., Zhang, L., Chawla, A., Macari, E. R., Pierciey, F. J., Tisdale, J. F., & Kanter, J. (2022). Lovo-cel (bb1111) Gene Therapy for Sickle Cell Disease: Updated Clinical Results and Investigations into Two Cases of Anemia from Group C of the Phase 1/2 HGB-206 Study. Blood, 140(Supplement 1), 26–28. https://doi.org/10.1182/blood-2022-162288
Authors:
Mark C. Walters
Alexis A. Thompson
Janet L. Kwiatkowski
Suhag Parikh
Markus Y. Mapara
Stacey Rifkin-Zenenberg
Banu Aygün
Kimberly A. Kasow
Alex Miller
Lixin Zhang
Anupama Chawla
Elizabeth R. Macari
Francis J. Pierciey
John F. Tisdale
Julie Kanter
Affiliated Authors:
Markus Y. Mapara
Publication Type:
Article
Unique ID:
10.1182/blood-2022-162288
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: